Latent Herpes Viruses Are Associated with Heart Disease According to PLoS One as Predicted by the Microcompetition Theory

Share Article

A new study in PLoS One published in January, 2013 says that infection with latent Epstein Barr Virus (EBV) may lead to heart disease and heart attacks, (1) as predicted by Dr. Hanan Polansky in his Microcompetition Theory.

Herpes treatment
viral infections can promote both the evolution of atherosclerosis and the occurrence of acute coronary events. - PLoS One

Everybody knows that high cholesterol can cause heart disease. Now, studies have shown that viruses can also cause atherosclerosis, the scientific name for heart disease. For many years, the scientific and medical communities believed that viruses may be dangerous but only when replicating and causing symptoms. They did not believe that while dormant, or latent, viruses can cause disease.

New research, published by PLoS One, has provided “the support for …the role of latent viral infections as an environmental risk factor for atherosclerosis and acute coronary events…..” (1) This research confirms the Microcompetition Theory introduced by Dr. Hanan Polansky in 2003. (2) The theory argues that foreign DNA fragments, called N-boxes, cause most major diseases including heart disease.

In the nucleus, "microcompetition" between the foreign N-boxes and the human N-boxes in the human genes can lead to a major disease. When the foreign N-boxes belong to a virus, microcompetition between the viral DNA and the human DNA can lead to disease even when the virus is latent (dormant), or the viral DNA is broken into pieces and cannot express proteins.

As predicted by Dr. Hanan Polansky, the PLoS One study shows that “viral infections can promote both the evolution of atherosclerosis (heart disease) and the occurrence of acute coronary events (heart attacks)…even during incomplete viral replication when there is a low viral load that is difficult to detect using standard analytic methods. This would account for the inability of some reports to confirm the presence of a virus such as EBV despite its proposed role in atherogenesis.” (1)

In simple terms, certain herpes viruses can lead to heart disease and heart attacks. The Epstein Barr virus (a herpes virus) may cause these conditions even when the numbers of EBVs in the body are extremely low, or when it is latent, that is, showing no signs of an infection. This means that people who feel completely healthy, yet are infected by EBV, are at risk of developing heart disease even if they keep their cholesterol low.

In light of the information published in this study, polyDNA recommends Gene-Eden-VIR, a natural EBV remedy. Gene-Eden-VIR is designed to fight against latent herpes viruses. By killing the latent EBV, one may help prevent heart disease from developing.

In fact, a recent post marketing clinical study showed that Gene-Eden-VIR is safe and effective. Up to 70% of those studied reported a decrease in EBV symptoms. (3)

Each ingredient of Gene-Eden-VIR was chosen through a scientific approach. Scientists scanned thousands of scientific and medical papers published in various medical and scientific journals around the world to identify the safest, most effective natural ingredients that target the latent form of the Epstein Barr Virus. (4)

To learn more about Gene-Eden-VIR, visit



polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.

polyDNA developed Gene-Eden-VIR , an antiviral natural remedy that helps the immune system kill latent viruses.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mike Davis
Visit website